Register online now or close this box to return to online registration.

The program will cover topics including: Corporate Protests and Extremism in the Pre-Clinical Testing Arena: Management and Legal Strategies; Managing Off-Label Issues and Risks in an Era of Increased Federal and State Enforcement; Risk Information Guidance and Social Media—Drugs versus Devices; FDA Chief Counsels Panel and a Keynote address by The Honorable David S. Cade, (Acting) General Counsel, U.S. Department of Health and Human Services, Washington, D.C.

Meeting
8:45 a.m. to 12:35 p.m.
Bryant Suite, 2nd Floor
Luncheon
1:00 p.m.
Trianon Ballroom, 3rd Floor

Click here to view the program agenda.